1 - 25 of 83
Number of results to display per page
TitleCreatorRelation Is Part Of
1 3T Assessment of Lateral Geniculate Nucleus Atrophy in Glaucoma and Correlation with Clinical Stage of DiseaseMorelli, John; Vu, Lan; Dai, Hui; Ai, Fei; Ketao, Mu; Qi, Jianpin; Wang, Chengyuan; Zhu, Wenzhen; Xia, LimingNANOS 2011: Poster Presentations
2 A Comparison of Multifocal Visual Evoked Potentials to Field Defects Due to Optic NeuropathyDonald C. Hood; Xian Zhang; Jeffrey G. OdelNANOS 2000: Scientific Platform Presentations (Session II)
3 Acute Angle Closure Glaucoma In A Patient With Miller Fisher Syndrome Without Pupillary DysfunctionWon Yeol Ryu, Jong Kuk KimNANOS 2015: Poster Presentations
4 Amyloid-B and Glaucoma: The Retinal Ganglion Cell- Neurotoxic ConnectionGrzybowski, Debroah M; Clint, Allred; Donahue, John; Glimcher, Shelley A; Lawhon, William; Johanson, Conrad; Stopa, Edward GNANOS 2008: Poster Presentations
5 Angle Closure Glaucoma Precipitated by Third Nerve PalsySmith, Thomas JNANOS 1987: Scientific Platform Presentations (Session 1)
6 Anterior Quadrant Head PainJ. M. BicknellNANOS 1980: Cerebellar Symposium
7 Anterior Quadrant Head PainJoseph M. BicknellNANOS 1980: Various Subjects Symposium (Session 3)
8 Association between Blepharospasm and GlaucomaLee, Michael; Lee, Paul; Grossman, Daniel; Harrison, Andrew; Sloan, FrankNANOS 2009: Poster Presentations
9 Automated Perimetry: a Comparison of Test Strategies for Patients with GlaucomaRamirez, Adriana M; Giaconi, JoAnn A; Gordon, LynnNANOS 2006: Poster Presentations
10 Autosomal Dominant Optic Atrophy: A Sheep in Wolf's Clothing?Katz, Steven E; Lubow, M; Earley, MNANOS 1996: Poster Presentations (Session 2)
11 Bi-Nasal Visual Field Defects Associated with Hemifield Slide-Related DiplopiaPula, John; Younis, Amjad; Eggenberger, EricNANOS 2008: Poster Presentations
12 Bitemporal Superior Quadrantic Defects Associated with an Anomalous A1Strominger, Mitchell BNANOS 1995: Poster Presentations (Session II)
13 Classification of Glaucomatous Visual Field Abnormalities in the Ocular Hypertension Treatment Study (OHTS)John L. Keltner, MD, UC Davis Health; Chris A. Johnson, MD, Devers Eye InstituteNANOS 2003: Poster Presentations
14 Classification of Visual Field Abnormalities 1, 5 and 10 Years after the Optic Neuritis Treatment Trial (ONTT)Keltner, John L; Johnson, Chris A; Cello, Kimberly E; Redline, Daniel ENANOS 2004: Scientific Platform Presentations (Session 2)
15 Comparison Of Optic Nerve Head Topography and Retinal Nerve Fiber Layer Thickness in Non-glaucomatous Optic Neuropathy (NGON) and Normal Tension Glaucoma (NTG)Chan, Noel CY; Hansapinyo, Linda; Cheng, Andy CO; Leung, Dexter YL; Chan, Carmen KMNANOS 2014: Poster Presentations
16 Comparison of Total Deviation Probability Plots Show Size V Testing is as Sensitive as Size III Automated Perimetry TestingMichael Wall; Caridad Brito; Kimberly Woodward; Carrie Doyle; Randy Kardon; Chris JohnsonNANOS 2008: Platform Session II
17 Confirmation of Visual Field Abnormalities in the Ocular Hypertension Treatment StudyJohn L. Keltner, MD, UC Davis Health; Chris A. Johnson, MD, Devers Eye Institute; Spurr, John O; Kass, Michael A; Gordon, Mae ONANOS 1998: Poster Presentations (Session II)
18 Differentiating Glaucomatous from Non-Glaucomatous Optic Nerve Cupping by Optical Coherence TomographyGupta, Preeya; Asrani, Sanjay; Freedman, Sharon; El-Dairi, Mays M.; Bhatti, TariqNANOS 2009: Poster Presentations
19 Driver Fitness in patients with Glaucoma and Cognitive ImpairmentRosen, Peter N; Boer, Erwin R; Weinreb, Robert N; Medeiros, Felipe ANANOS 2012: Poster Presentations
20 Eye movement perimetry for evaluation of visual field loss in patients with glaucoma versus recovered optic neuritisThurtell, Matthew J; Warren, David E; Xu, Alice; Papendieck, Andrew; Wall, Michael HNANOS 2014: Poster Presentations
21 Factitious Visual LossTerry A. CoxNANOS 2003: Controversies Session
22 Frequency Doubling Perimetry in Neuro-Ophthalmologic Disorders: A Comaprison with Conventional Automated PerimetryWall, Michale; Neahring, R; Woodward, KScientific Platform Presentations (Session II)
23 Gabapentin-Lactam: A Novel Neuroprotective AgentWolf-Dietrich A. Lagreze; Rike R. Muller-Velten; Thomas J. FeuersteinNANOS 2000: Scientific Platform Presentations (Session I)
24 Glalucomatous Visual Field DefectBedrossian, Robert HNANOS 1982: Scientific Platform Presentations (Session 3)
25 Glaucoma as a Neurological DiseaseHelen V. Danesh-MeyerNANOS Annual Meeting 2015 Glaucoma: The Other Optic Neuropathy
1 - 25 of 83